Michael Zepp
Impact in
-
- Chemokine receptors and signaling
- Bone health and treatments
- Cancer Immunotherapy and Biomarkers
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
-
- Glycosylation and Glycoproteins Research 3
- FOXO transcription factor regulation 2
- Oncology 11
- Chemokine receptors and signaling 4
- Pancreatic and Hepatic Oncology Research 3
- Co-authors
- Martin R. Berger (24 shared papers)Hassan Adwan (7 shared papers)Asim Pervaiz (5 shared papers)Stefan Berger (3 shared papers)Saqib Mahmood (2 shared papers)Ergül Eyol (4 shared papers)Frank Bergmann (3 shared papers)Gershon Golomb (2 shared papers)
In The Last Decade
Michael Zepp
25 papers receiving 396 citations
Peers
Comparison fields: 5 of 62
- Oncology 154
- Immunology 96
- Cancer Research 56
- Immunology and Allergy 16
- Molecular Biology 157
Countries citing papers authored by Michael Zepp
This map shows the geographic impact of Michael Zepp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Zepp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Zepp more than expected).
Fields of papers citing papers by Michael Zepp
This network shows the impact of papers produced by Michael Zepp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Zepp. The network helps show where Michael Zepp may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Zepp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 54 | |
| 2 | 2020 | 32 | |
| 3 | 2012 | 31 | |
| 4 | 2011 | 30 | |
| 5 | 2020 | 30 | |
| 6 | 2020 | 30 | |
| 7 | 2019 | 28 | |
| 8 | 2015 | 25 | |
| 9 | 2019 | 24 | |
| 10 | 2014 | 19 | |
| 11 | 2012 | 15 | |
| 12 | 2017 | 15 | |
| 13 | 2018 | 14 | |
| 14 | 2010 | 12 | |
| 15 | 2024 | 7 | |
| 16 | 2020 | 6 | |
| 17 | 2017 | 6 | |
| 18 | 2018 | 5 | |
| 19 | 2023 | 4 | |
| 20 | 2020 | 3 |
About Michael Zepp
Michael Zepp is a scholar working on Molecular Biology, Oncology, Rheumatology, Immunology and Cancer Research, having authored 25 papers that have together received 399 indexed citations. Recurring topics across this work include Bone and Dental Protein Studies (6 papers), Chemokine receptors and signaling (4 papers), Glycosylation and Glycoproteins Research (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Galectins and Cancer Biology (2 papers), FOXO transcription factor regulation (2 papers), Nanoparticle-Based Drug Delivery (2 papers) and Oral and Maxillofacial Pathology (2 papers). The work is most often cited by research in Oncology (154 citations), Immunology (96 citations), Cancer Research (56 citations), Immunology and Allergy (16 citations) and Molecular Biology (157 citations). Michael Zepp has collaborated with scholars based in Germany, Egypt and Pakistan. Frequent co-authors include Martin R. Berger, Hassan Adwan, Asim Pervaiz, Stefan Berger, Saqib Mahmood, Ergül Eyol, Frank Bergmann, Gershon Golomb, Michaela Knapp‐Mohammady and Huiying Huang. Their work appears in journals such as Journal of Cancer Research and Clinical Oncology, Genes & Cancer, Oncotarget, Experimental Biology and Medicine and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.